Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004

This publication has 15 references indexed in Scilit:

• Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
  Vaccine, 2004
• Role of CD8⁺T Cells in Control of West Nile Virus Infection
  Journal of Virology, 2004
• Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
  The Journal of Infectious Diseases, 2003
• Efficacy of single-dose SA 14–14–2 vaccine against Japanese encephalitis: a case control study
  The Lancet, 2001
• Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization Schedules
  The Journal of Infectious Diseases, 1998
• Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study
  The Lancet, 1996
• Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells
  Journal of General Virology, 1996
• Protection against Japanese Encephalitis by Inactivated Vaccines
  New England Journal of Medicine, 1988
• Japanese Encephalitis Vaccine
  Pediatrics International, 1988
• Booster vaccination with further live attenuated measles vaccine
  Published by American Medical Association (AMA) ,1976